| |
|
|
|
|
|
|
|||
|
Extending a welcome into the uterine bed...Mammalian pregnancy represents an immunologic paradigm. Not only does the maternal immune system recognize the fetoplacental unit but it creates an environment in which the developing fetus will flourish. A subpopulation of natural killer (NK) cells is of particular interest. These cells accumulate and proliferate in decidualizing human uteri anticipating successful implantation of the embryo. As part of the innate immune system, uterine NK cells are well-qualified to seek out and destroy foreign tissue, such as fetal trophoblast cells, that form the placenta, but in pregnant uteri they appear to lack cytotoxicity. Rather, a key role hypothesized for uterine NK cells is to participate in physiologic changes to maternal arteries through cytokine secretion. The changes optimize blood flow into the feto-placental unit and presumably require positional information from invasive fetal trophoblast cells. In primate uteri, NK cells appear in 2 waves: the first wave is in the postovulatory period of each menstrual cycle when uterine stromal cells undergo transformation to decidua, and the second wave is in response to implantation and pregnancy. Terminal differentiation and proliferation of NK cells occur in the uterus. Although decidua-associated NK cells have been reported in many species, the mechanisms explaining their recruitment are mysterious.
Previously, subsets of peripheral blood NK cells (CD56bright,
CD56dim, and NK-T) were shown to express distinct patterns of
chemokine receptors and responsiveness. Hanna and colleagues (page
1569), in a series of
exacting experiments, build on this approach to explore the role of
uterine-secreted chemokines in NK-cell recruitment to pregnant uterus. From
analyses of mRNA, protein, and the function of chemokine receptors of uterine
CD56+CD16 NK cells and CD16 and
CD16+ peripheral blood NK cells, 2 pivotal insights were revealed.
Uterine NK cells, shown to express unusually high levels of CXCR4 and
blood-equivalent levels of CXCR3, are recruited within implantation sites by a
specific subset of fetal placental cells called extravillous trophoblasts.
These trophoblasts, which reside in the decidua and replace maternal
endothelium in the major decidual arteries, are the only trophoblast subsets
expressing CXCL12 (stromal cellderived factor-1
Interleukin 15 (IL-15), a cytokine essential for NK-cell differentiation
and showing regulated expression in early decidua and uterine arterial
endothelium, gave NK cells in blood lymphocyte cultures a uterine NK-cell
chemokine receptor expression profile. This, plus the finding that
transforming growth factor-
Related Article in Blood Online:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2003 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||